Notably, considering the endothelial compartment as an essential component of the cancer microenvironment and its role in angiogenesis, several inhibitors of the p38 pathways show interesting potential in inhibiting cancer progression via inhibition of angiogenesis. This evidence concerns the gene MAPK1 and cancer.